2003

Jan 13, 2003
Guidant Announces FDA Approval of Advanced Heart Failure Technology

CONTAK RENEWAL Includes State-of-the-Art Therapies and Diagnostics for Improved Management of Heart Failure Patients Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a...

Jan 10, 2003
Guidant Strengthens Advanced Patient Management Initiative with Increased CardioNet Investment

Wireless Telecommunications Enable Remote Monitoring of Heart Patients with Implanted Devices Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Jan 7, 2003
Guidant Pre-Announces 2002 Fourth Quarter Revenues

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced preliminary fourth quarter revenues of approximately...

Jan 2, 2003
Guidant to Participate in JPMorgan H&Q 21st Annual Healthcare Conference

Guidant Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it...

Jan 2, 2003
Guidant Reports Preliminary Results of DELIVER Clinical Trial

Conditions to Closing Guidant-Cook Merger Not Satisfied Company to Host Webcast/Conference Call January 3 at 8:30 AM EST Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world...

Jan 2, 2003
Guidant to Acquire Biosensors'' Everolimus Eluting Stent Assets

Agreement Strengthens Guidant''s Everolimus Eluting Stent Program Company to Host Webcast/Conference Call January 3 at 8:30 AM EST Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a...

Jan 7, 2003
Guidant Named One of FORTUNE's 100 Best Companies To Work For

Company Named To Prestigious Ranking For Fourth Time In Five Years Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease,...

Show per page

Top